GET THE APP

Maternal and Pediatric Nutrition

Maternal and Pediatric Nutrition
Open Access

ISSN: 2472-1182

Commentary - (2022)Volume 7, Issue 6

Hormonal Regulation of Insulin during Pregnancy by Chromium

Susan Stephen*
 
*Correspondence: Susan Stephen, Department of Nutrition and Food Science, Pharmacy School, Universidad Complutense de Madrid, Spain, Email:

Author info »

Description

Chromium (Cr) regulates the insulin hormonal response in the body during pregnancy. Chromium is necessary for a wide range of metabolic processes, including regulating glucose and lipid levels. Because there aren't many reliable ways to measure chromium status or the amount of chromium in foods, it's hard to know how much chromium an older person needs. Chromium is an essential mineral that appears to regulate insulin action and its effects on carbohydrate, protein, and lipid metabolism in a beneficial manner. When it comes to boosting insulin activity, chromium plays a significant role. Chromium levels in the blood of people with type 2 diabetes are lower than those of people without diabetes.

Chromium appears to work with insulin to help maintain a normal level of glucose in the human body. Chromium is necessary during pregnancy, if a pregnant woman has diabetes or develops gestational diabetes. Meats, grains, fruits, and vegetables top the list of foods rich in chromium, they don't need a chromium supplement if they take a chromium-rich prenatal vitamin or eat chromium-rich foods. An essential trace mineral is chromium, two types exist hexavalent chromium, which is toxic, and trivalent chromium, which is safe for humans. Supplements and foods contain chromium trivalent. By improving insulin is used by the body, it might help to maintain normal blood sugar levels.

The body may benefit from the mineral chromium's ability to break down and store protein, carbohydrates and fats. Additionally, it appears to cooperate with the hormone insulin in order to maintain a normal glucose level in pregnant women's Trivalent chromium (Cr) is considered an essential element, which has a daily allowance of 50–200 mg for adults of both men and women. Along with insulin, chromium also encourages the formation of proteins in the developing tissues of babies.

A condition known as Gestational Diabetes Mellitus (GDM) occurs when the body is unable to effectively use insulin due to a hormone that is produced by the placenta. Instead of getting into the cells, glucose builds up in the blood. Gestational diabetes, in contrast to type 1 diabetes, is not caused by a lack of insulin, it is caused by other hormones produced during pregnancy that have the potential to make insulin less effective, a condition known as insulin resistance. After birth, gestational diabetes symptoms reduces.

The placenta not only produces a variety of hormones to keep the pregnancy going, but it also provides a growing fetus with nutrients and water. Estrogen, cortisol, and human placental lactogen are three of these hormones that have the potential to inhibit insulin. Contra-insulin effect typically appears between 20 and 24 weeks into a pregnancy. These hormones are produced in greater quantities as the placenta develop, raising the possibility of developing insulin resistance. When the pancreas produces insufficient insulin to prevent the effects of placental hormones, gestational diabetes results. In normal circumstances, the pancreas is able to produce additional insulin to overcome insulin resistance. Hemodilution occurs as a result of an increase in blood volume and glomerular filtration rate during pregnancy. Cr may be eliminated from the maternal circulation as a result of an increased urinary output. The growing Insulin Resistance (IR) that can predispose to GDM can be aggravated if adequate dietary replacement is not met.

Author Info

Susan Stephen*
 
Department of Nutrition and Food Science, Pharmacy School, Universidad Complutense de Madrid, Spain
 

Citation: Stephen S (2022) Hormonal Regulation of Insulin during Pregnancy by Chromium. Matern Pediatr Nutr. 7:178.

Received: 29-Nov-2022, Manuscript No. MPN-23-21577; Editor assigned: 01-Dec-2022, Pre QC No. MPN-23-21577 (PQ); Reviewed: 15-Dec-2022, QC No. MPN-23-21577; Revised: 22-Dec-2022, Manuscript No. MPN-23-21577 (R); Published: 29-Dec-2022 , DOI: 10.35248/2472-1182.22.7.178

Copyright: © 2022 Paul D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top